Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cannara Biotech Inc. V.LOVE

Alternate Symbol(s):  LOVFF

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for the Quebec and Canadian markets. The company owns two mega Quebec-based facilities. Leveraging Quebec's low electricity and labor rates, Cannara's facilities produce handcrafted premium-quality cannabis at affordable prices.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

Cannara Biotech Inc. to Host Investor Webcast on August 17th

MONTREAL, Aug. 10, 2022 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer more

RE:Horrible employer

ta perdu ton emploie ou ta perdu de argent tu a l'air frustr   rate and reply

Neovasc Announces Second Quarter Financial Results

Generated revenues of $818,000, a quarterly record and a year-over-year increase of 29% over the second quarter of 2021. And COSIRA II protocol supplement was approved by the FDA, more than doubling the total number of patients and adding specific patient groups eligible and allowed for treatment in the trial. more

RE:RE:RE:Cannara Biotech Inc. Closes $50 Million Credit Facility

July 27, news is out and they make money in Q3  rate and reply

Horrible employer

This company is horrible to it's employees. As an ex-employee I can back this statement. Under paid wages. Racists toward the english and expects over-time for employees almost daily. It has more

RE:RE:Cannara Biotech Inc. Closes $50 Million Credit Facility

sorry but this not great news. We don't know the interest rate. Since it declines with milestones one can assume it is a few points above prime.  rate and reply

RE:Cannara Biotech Inc. Closes $50 Million Credit Facility

sa inogure bien pour love encore un peu de patience   rate and reply

Cannara Biotech Inc. Closes $50 Million Credit Facility

MONTREAL, June 1, 2022 /CNW Telbec/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically more


no they lost money. These guys have the most creative reporting system ever. That is the reason all the institutions dumped this stock.  rate and reply


Q2,  27 April, did they make a good profit , not sure ?  rate and reply

RE:.18 Forever

  rate and reply

I see

This dik stik is sukn it. Sweeeeet  rate and reply

RE:RE:RE:Cannara  rate and reply


28-02-2022  OLDS, DONALD JOHN insider buy 10000 shares at $0.115. Not very strong!  rate and reply


Nicholas Sosiak buy 47000 shares at 12.5 c.  rate and reply

Cannara  rate and reply


Lots of jobs available at Cannara. ( See on the site )  rate and reply


876,000,000 *.13 =110M$ is the buiding value paid by tgod insider Stern Richard (163.5K shares)(Olympic invt. (a lanlord invt corp)), Alan D. Richard also in for 163k shares; total 326/876k= 37% more


hi 876,000,000 x ,32 = 280000000 market cap kind of optimistic. As I said sell into any rally. Besides for a company with a 142 million cap they still do not report in a professional manner. No more


Hey, Twitzer old freind! Another shot at bottom fishing this morning! Q4  =  .01 x 4 for a fiscal yr = .04 x 8 (conservative stock market multiple)  = 0.32 Try as hard as you more

Fourth Quarter and Fiscal Year 2021 Results

Fiscal 2021 revenues of $17.3 million, gross profit of $10.5 million or 61% and an Adjusted EBITDA of $1.5 million, strong indicators of Cannara's performance and more